ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,612Medicare Part D Prescriptions Filled, Including Refills

Rank: 45 out of 749

$926K Total Retail Price of All Prescriptions

Rank: 36 out of 749

381 Patients Receiving at Least One Drug in Part D
57%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 381 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

20% of this provider’s 381 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

2% of this provider’s 3,644 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 31%.

Prescription Price

$122 was the average price of a prescription from this provider, compared to $116 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 430 201 1 1
RENVELA 405 198 2 3
FUROSEMIDE 320 203 3 2
OMEPRAZOLE 272 148 4 6
LISINOPRIL 262 135 5 4
METOPROLOL TARTRATE 233 64 6 7
CALCIUM ACETATE 228 74 7 16
HYDROCODONE-ACETAMINOPHEN 217 56 S3 8 12
SIMVASTATIN 208 135 9 5
SENSIPAR 204 47 10 8
CLONIDINE HCL 173 20 11 15
GLIPIZIDE 163 97 12 32
CARVEDILOL 154 85 13 11
HYDRALAZINE HCL 138 64 14 19
LOSARTAN POTASSIUM 133 115 15 9
LEVOTHYROXINE SODIUM 125 86 16 13
INSULIN SYRINGE 116 46 17 41
GABAPENTIN 114 30 18 25
ATORVASTATIN CALCIUM 103 47 19 18
DIOVAN 87 49 20 14
RENAGEL 85 15 21 50
LANTUS 83 44 22 36
FOSRENOL 80 20 23 76
ALLOPURINOL 77 42 24 10
METFORMIN HCL 74 62 25 22
JANUVIA 69 52 26 33
BENAZEPRIL HCL 68 34 27 23
MINOXIDIL 61 0 28 59
NOVOLIN R 59 23 29 180
ACETAMINOPHEN-CODEINE 58 45 S3 30 79
MEGESTROL ACETATE 57 39 R 31 69
TAMSULOSIN HCL 54 31 32 29
ATENOLOL 54 28 32 20
METOCLOPRAMIDE HCL 53 12 34 74
GEMFIBROZIL 53 34 34 129
LABETALOL HCL 51 16 36 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 29, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.